Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
04 May 2023 | Story Lunga Luthuli | Photo Supplied
Juanita
As a member of the USAf Leadership Management Strategy Group, Juanita Burjins will help member universities and other key role players with their leadership and management development needs.

Juanita Burjins, Head: Leadership and Development in the Department of Human Resources at the University of the Free State, was recently appointed as a member of the Universities South Africa’s Leadership Management Strategy Group (LMSG). The appointment to the group in April 2023 is a testament and a recognition of Burjin’s leadership and expertise, not only in the field of human resources but also in the higher education sector.

The LMSG is responsible for initiating activities that would allow it to develop evidence-based influences on the work of Higher Education Learner Management (HELM), and to advise the board on the programmatic direction of HELM, including its financial sustainability and identifying opportunities for the growth and expansion of its post-school education and training.

As a member of the USAf Leadership Management Strategy Group – a position Burjins will hold for three years – she will contribute and provide strategic advice to the USAf Board, the Chief Executive, and the Director of Higher Education Leadership and Management, regarding planning, implementation, and monitoring. 

Burjins said: “I was nominated by the Skills Development Facilitators Forum; in the group, I will be responsible for engagement and alignment with member universities and other key role players in terms of their leadership and management development needs.”  

Beaming with pride, Burjins is looking forward to “working with a group of expert leaders within the higher education sector and contributing to enabling and empowering learning opportunities”. 

“I am proud that I could represent the University of the Free State in this capacity and contribute to the stability and effectiveness of institutional leadership and management in the higher education sector. With the opportunity, I am also looking forward to providing strategic advice, advocacy, and tactical programme management support for HELM, and identifying potential national and regional collaborations and partnerships with other universities,” added Burjins.

Burjins believes it is important to have the USAf Leadership Management Strategy Group in higher education, as it provides ‘strategic advice to the USAf Board on the planning, implementation, and monitoring of HELM for the engagement and alignment of member universities in terms of the leadership and development needs as well as the relevance and responsiveness of programme offering and other services in leadership and development.

News Archive

National Department of Health invests R53.5 million in UFS laboratory
2016-02-04

Description: Dr Derek Litthauer Tags: Dr Derek Litthauer

Dr Derek Litthauer
Photo: Supplied

This year has started off on a high note for Dr Derek Litthauer and his team at the South African National Control Laboratory (NCL) for Biological Products. The National Department of Health has awarded the NCL a contract to the value of R53.5 million to continue testing vaccines for the next three years.

Vaccines are biological medicines used to ensure healthy populations by preventing many diseases. The World Health Organization (WHO) estimates that, worldwide, about 5.2 million children under six years old die annually. Of these deaths, 29% are vaccine preventable. Research has revealed that vaccines prevent about 6 million deaths each year globally. Safe and effective vaccines are essential public health tools, which are strictly regulated internationally. It is the NCL’s responsibility to perform quality control testing on all vaccines to be used on humans in South Africa.

This laboratory, the only one of its kind in Africa, receives samples of vaccines from manufacturers and importers for rigorous evaluation and testing. No vaccine may be used in South Africa without a release certificate issued by the Control Lab, certifying that the vaccine is suitable for human use.

The contract is a commitment to ensuring that only vaccines of the highest quality are used in South Africa.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept